Open Access<p>Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma</p>
Author(s) -
Omaima Ali,
Hussein Ahmed El Amin,
Yousry Lotfy Sharkawy,
Adnan Ahmed Ali,
Emad Farah Mohammed Kholef,
Wael Abd Elgwad Elsewify
Publication year - 2020
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s253622
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , biomarker , gastroenterology , alpha fetoprotein , liver function , hepatitis b , liver function tests , pathology , biochemistry , chemistry
Screening of early hepatocellular carcinoma (HCC) diagnosis is the greatest challenge for hepatologists. Alpha-fetoprotein (AFP) is the most common non-invasive biomarker used in HCC diagnosis.